Sensus Healthcare resumes $3M share repurchase program, citing compelling opportunity

Sensus Healthcare, Inc.

Resumes purchases under $3.0M buyback program approved August 2023; 9,427 shares already repurchased.
CEO Joe Sardano says repurchase is compelling at current prices; completed similar $3M program in 2022.
Program is discretionary; may be suspended or discontinued at any time at company's discretion.
Company remains confident in growth prospects and strategic initiatives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.